Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $741.00K in the quarter ending September 30, 2025, a decrease of -41.61%. This brings the company's revenue in the last twelve months to $2.65M, down -55.88% year-over-year. In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%.

• Revenue (ttm): $2.65M
• Revenue Growth: -55.88%
• P/S Ratio: 31.85
• Revenue / Employee: $37,800
• Employees: 70
• Market Cap: 58.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.95M	-11.58M	-74.60%
Dec 31, 2023	15.53M	1.62M	11.66%
Dec 31, 2022	13.91M	9.55M	219.04%
Dec 31, 2021	4.36M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-